Compared to currently approved drugs prescribed for the treatment of Alzheimer's disease, THC is a considerably superior inhibitor of Abeta aggregation, and this study provides a previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.
Link: A Molecular Link Between The Active Component Of Marijuana And Alzheimer's Disease Pathology
Year: 2006
DOI: 10.1021/mp060066m
Possibility of efficacy for cannabis in treatment of Alzheimer's Disease according to the results found in this study.
THC